Literature DB >> 8949656

Inhibition of acetylcholine induced intestinal motility by interleukin 1 beta in the rat.

A C Aubé1, H M Blottière, C Scarpignato, C Cherbut, C Rozé, J P Galmiche.   

Abstract

BACKGROUND/AIMS: The fact that raised interleukin 1 beta (IL 1 beta) concentrations have been found in the colonic mucosa of rats with experimentally induced colitis and of patients with inflammatory bowel disease indicates that this cytokine may participate in the disturbed intestinal motility seen during inflammatory bowel disease. This study investigated whether IL 1 beta could change the contractility of (a) a longitudinal muscle-myenteric plexus preparation from rat jejunum, ileum, and colon and (b) isolated jejunal smooth muscle cells.
METHODS: Isometric mechanical activity of intestinal segments was recorded using a force transducer. Moreover, smooth muscle cell length was measured by image analysis.
RESULTS: Although IL 1 beta did not affect jejunal, ileal, and colonic basal contractility, it significantly reduced contractile response to acetylcholine (ACh). This significant inhibition was seen only after 90 or 150 minutes of incubation with IL 1 beta. Pretreatment with cycloheximide blocked IL 1 beta induced inhibition of ACh stimulated jejunal contraction, suggesting that a newly synthesised protein was involved in the effect. NW-nitro-L-arginine (a nitric oxide synthase inhibitor) did not prevent the inhibition induced by IL 1 beta. Blocking neural transmission with tetrodotoxin abolished the IL 1 beta effect on jejunal contractile activity, whereas IL 1 beta had no effect on isolated and dispersed smooth muscle cells.
CONCLUSIONS: IL 1 beta inhibits ACh induced intestinal contraction and this inhibitory effect involves protein synthesis but is independent of nitric oxide synthesis. This effect does not involve a myogenic mechanism but is mediated through the myenteric plexus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949656      PMCID: PMC1383358          DOI: 10.1136/gut.39.3.470

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Interaction of acetylcholine and cholecystokinin with dispersed smooth muscle cells.

Authors:  K N Bitar; A M Zfass; G M Makhlouf
Journal:  Am J Physiol       Date:  1979-08

2.  Interleukin 1 inhibits contraction of vascular smooth muscle.

Authors:  D Beasley; R A Cohen; N G Levinsky
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

Authors:  Y R Mahida; K Wu; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

Review 4.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

5.  Altered neuropeptide content and cholinergic enzymatic activity in the inflamed guinea pig jejunum during parasitism.

Authors:  J M Palmer; T R Koch
Journal:  Neuropeptides       Date:  1995-05       Impact factor: 3.286

6.  Interleukin 1 induces a neurally mediated colonic secretion in rats: involvement of mast cells and prostaglandins.

Authors:  V Theodorou; H Eutamene; J Fioramonti; J L Junien; L Bueno
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

7.  Evidence that interleukin-1 beta and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway.

Authors:  P Montuschi; G Tringali; D Currò; G Ciabattoni; L Parente; P Preziosi; P Navarra
Journal:  Eur J Pharmacol       Date:  1994-02-11       Impact factor: 4.432

8.  Interleukin 1 beta induces the expression of interleukin 6 in rat intestinal smooth muscle cells.

Authors:  I Khan; M G Blennerhassett; G V Kataeva; S M Collins
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

9.  Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.

Authors:  A Woywodt; P Neustock; A Kruse; K Schwarting; D Ludwig; E F Stange; H Kirchner
Journal:  Eur Cytokine Netw       Date:  1994 Jul-Aug       Impact factor: 2.737

10.  In vitro contractile effects of short chain fatty acids in the rat terminal ileum.

Authors:  C Cherbut; A C Aubé; H M Blottière; P Pacaud; C Scarpignato; J P Galmiche
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

View more
  17 in total

1.  IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system.

Authors:  Y Xia; H Z Hu; S Liu; J Ren; D H Zafirov; J D Wood
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

3.  The enigmatic role of cholinergic reflex in the pathogenesis of Chagas disease.

Authors:  Luiz G F de A B D'Elia Zanella; Agnaldo Bruno Chies; Maria Angélica Spadella; Altino Luiz Silva Therezo; Patrícia de Souza Rossignoli; Fernando Frei; Luciamáre Perinetti Alves Martins
Journal:  Parasitol Res       Date:  2014-04-01       Impact factor: 2.289

4.  Effect of experimental acalculous cholecystitis on gallbladder smooth muscle contractility.

Authors:  H P Parkman; L J Bogar; L L Bartula; A P Pagano; R M Thomas; S I Myers
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

5.  Pathways and receptors involved in peptide YY induced contraction of rat proximal colonic muscle in vitro.

Authors:  L Ferrier; J P Segain; P Pacaud; C Cherbut; G Loirand; J P Galmiche; H M Blottière
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.

Authors:  Wenhui Hu; Sunila Mahavadi; Fang Li; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-24       Impact factor: 4.249

7.  Rhythmic changes in colonic motility are regulated by period genes.

Authors:  Willemijntje A Hoogerwerf; Vahakn B Shahinian; Germaine Cornélissen; Franz Halberg; Jonathon Bostwick; John Timm; Paul A Bartell; Vincent M Cassone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

8.  Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.

Authors:  Wenhui Hu; Fang Li; Sunila Mahavadi; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-15       Impact factor: 4.249

9.  Effects of leptin on cat intestinal motility.

Authors:  Stéphanie Gaigé; Anne Abysique; Michel Bouvier
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

10.  An opioid receptor-independent mechanism underlies motility dysfunction and visceral hyperalgesia in opioid-induced bowel dysfunction.

Authors:  You-Min Lin; Yanbo Tang; Yu Fu; Shrilakshmi Hegde; Daniel W Shi; Li-Yen M Huang; Xuan-Zheng Shi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-04-28       Impact factor: 4.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.